Detection of Prostate Carcinoma in an Asymptomatic Individual Initiated by an Immunological Biopsy-A Case Report [0.03%]
免疫活检发现的一例无症状前列腺癌患者——病例报告
Simon Burg,Audrey Laure Céline Grust
Simon Burg
Background: With a total of 1.46 million new cases and 396,792 deaths in 2022, prostate cancer is a major medical challenge around the world. Detecting and treating cancer at earlier, preferably localized stages can signi...
Case Reports
Oncology research. 2026 Jan 19;34(2):26. DOI:10.32604/or.2025.068555 2026
Rare Multiple Brain Metastases Following Debulking Surgery and Androgen Deprivation Therapy in Aggressive Prostate Cancer-Case Report [0.03%]
前列腺癌手术和去势术后罕见多发脑转移一例报告
Andong Cheng,Yiding Chen,Hao Li et al.
Andong Cheng et al.
Background: In clinical practice, approximately 80% of prostate cancer (PC) cases are localized and can achieve favorable outcomes with appropriate treatment. Conversely, some remaining cases exhibit an aggressive phenoty...
Case Reports
Oncology research. 2026 Jan 19;34(2):27. DOI:10.32604/or.2025.066478 2026
Thimerosal Inhibits Tumor Malignant Progression through Direct Action and Enhancing the Efficacy of PD-1-Based Immunotherapy [0.03%]
硫汞化合物可通过直接作用和增强PD-1免疫疗法的疗效来抑制肿瘤恶性进展
Ping Wang,Yan-Han Chen,Ze-Tao Zhan et al.
Ping Wang et al.
Background: Thimerosal is a mercury-containing preservative widely used in vaccines. This study aimed to investigate its potential antitumor effects and mechanisms in solid malignancies, particularly colorectal cancer (CR...
Parasitic Infections and Carcinogenesis: Molecular Mechanisms, Immune Modulation, and Emerging Therapeutic Strategies [0.03%]
寄生虫感染与肿瘤发生：分子机制、免疫调控及治疗新策略
Marta Pawłowska,Dorian Jarek,Jan Milanowski et al.
Marta Pawłowska et al.
Parasitic infections are increasingly recognized as contributors to cancer development, yet the underlying oncogenic mechanisms remain insufficiently understood. Growing evidence from molecular oncology, immunology, and microbiome research ...
Gut Associated Metabolites Enhance PD-L1 Blockade Efficacy in Prostate Cancer [0.03%]
与肠道相关的代谢产物可增强PD-L1阻断在前列腺癌治疗中的疗效
Ke Liu,Xia Xue,Haiming Qin et al.
Ke Liu et al.
Background: The gut microbiome has emerged as a critical modulator of cancer immunotherapy response. However, the mechanisms by which gut-associated metabolites influence checkpoint blockade efficacy in prostate cancer (P...
Retraction: ABCB5-ZEB1 Axis Promotes Invasion and Metastasis in Breast Cancer Cells [0.03%]
撤稿：ABCB5-ZEB1轴促进乳腺癌细胞的侵袭和转移
Oncology Research Editorial Office
Oncology Research Editorial Office
[This retracts the article DOI: 10.3727/096504016X14734149559061.]. © 2026 The Author.
The FN1-ITGB4 Axis Drives Acquired Chemoresistance in Bladder Cancer by Activating FAK Signaling [0.03%]
FN1-ITGB4轴通过激活FAK信号传导驱动膀胱癌获得性化疗抗性
Xiaoyu Zhang,RenFei Zong,Yan Sun et al.
Xiaoyu Zhang et al.
Objective: While cisplatin-based chemotherapy is pivotal for advanced bladder cancer, acquired resistance remains a major obstacle. This study investigates key molecular drivers of this resistance and potential reversal s...
Cancer-Associated Fibroblasts in Prostate Cancer: Unraveling Mechanisms and Therapeutic Implications [0.03%]
前列腺癌相关成纤维细胞：阐明机制和治疗意义
Yang Wu,Dong Xu,Run Shi et al.
Yang Wu et al.
Prostate cancer (PCa) remains a major cause of cancer-related mortality in men, largely due to therapy resistance and metastatic progression. Increasing evidence highlights the tumor microenvironment (TME), particularly cancer-associated fi...
The Frontier of Melanoma Treatment: Defeating Immunotherapy Resistance-A Systematic Review [0.03%]
melanoma治疗前沿：克服免疫疗法耐药性-系统评价
Kamila Mozga,Olga Synowiecka,Igor Rydzyk et al.
Kamila Mozga et al.
Objectives: Immunotherapy based on immune checkpoint blockade (ICB) has become a key treatment for melanoma. However, the increasing number of cases of melanoma resistant to immunotherapy highlights the need to develop me...
Prognostic Value of Circulating Tumor Cells and Cancer Associated Macrophage-Like Cells in Metastatic Non-Small Cell Lung Cancer Patients: A Retrospective Exploratory Analysis [0.03%]
循环肿瘤细胞和癌相关巨噬细胞样细胞在转移性非小细胞肺癌患者中的预后价值：一项回顾性探索性分析
Marco Siringo,Michela De Meo,Alain Jonathan Gelibter et al.
Marco Siringo et al.
Objectives: Although immune checkpoint inhibitors (ICIs) and targeted therapies have reshaped treatment non-small cell lung cancer (NSCLC) paradigms, prognosis remains poor for many patients due to delayed diagnosis and r...